T
HALO icon

TradeWorx’s Halozyme HALO Stock Holding History

TradeWorx’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-19,540
Closed -$248K – 386
2014
Q1 		$248K Sell
19,540
-8,501
-30% -$126K 0.22% 223
2013
Q4 		$420K Buy
28,041
+5,172
+23% +$66.5K 0.18% 194
2013
Q3 		$252K Buy
22,869
+11,728
+105% +$97.7K 0.12% 306
2013
Q2 		$89K Buy
+11,141
New +$71K 0.04% 450

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TradeWorx's HALO Position: Q2 2014 in Review

TradeWorx sold out of Halozyme (HALO) in Q2 2014, closing a stake of 19,540 shares — an estimated $248K sold.

TradeWorx first reported a position in HALO in Q2 2013 and held it in 4 quarters. The position peaked at $420K in Q4 2013. 128 funds tracked by Wall St. Rank hold HALO as of Q2 2014.

  • TradeWorx reported no remaining Halozyme position as of Q2 2014 after selling out during the quarter.
  • TradeWorx sold 19,540 Halozyme shares in Q2 2014, an estimated $248K.
  • TradeWorx first reported a position in Halozyme in Q2 2013 and held it in 4 quarters.
  • TradeWorx's Halozyme position peaked at $420K in Q4 2013.
  • 128 funds tracked by Wall St. Rank held Halozyme as of Q2 2014.

Based on TradeWorx's 13F filing for Q2 2014, filed 10 Jul 2014.